HCL Technologies announced the acquisition of C3i Solutions, a provider of customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck & Co., Inc., Kenilworth, New Jersey, U.S.A.
Financial details were not disclosed.
The acquisition will support HCL to expand its IT and business services capability to the life sciences and CPG verticals. C3i has expertise in the clinical, pharmacovigilance, and pharma sales support domains.
The deal will build on HCL’s footprint in consumer services, especially as an early leader in applying advanced analytics, IoT and creating digitised operations to create a better customer experience.
“This acquisition will allow HCL to help its life sciences customers become more patient-centric and develop solutions to address the digital revolution happening within their industry,” said C Vijayakumar, president and CEO, HCL Technologies.